4[1]Klijn CJ, Hankey GJ. Management of acute ischaemic stroke: new guidelines from the American stroke Association and European Stroke Imitiation. Lancet Neurol2003;2(11):698 -701
5[15]Bath PM, Iddenden R, Bath FJ. Low-molecular-weight heparins and heparinoids in acute ischemic stroke a meta-analysis od randomized controlled trails. Stroke2000;2(11): 1770 -8
6[16]Jenkinson D. Thrombolytic therapy for acute ischemic stroke. Hosp Med 2004; 65(3): 164 -9
7[17]Samsa GP, Matchar DB, Williams GR, et al. Cost-effectiveness of ancrod treatment of acute ischaemic stroke: results from the Stroke Treatment with Ancrod Trial(STAT). J Eval Clin Pract 2002; 8(1): 61 -70
8[18]Murry V. Thrombolytin therapy in acute ischemic stroke. Lakartidmingen 2004;101 ( 18): 662 - 73
9[19]Koemecke HC. Secondary prevention of stroke: a practical guide to drug treatment. CNS Drugs 2004; 18(4): 220-41
10[20]Young B, Runge JW, Waxman KS, et al. Effects of pegorgotein on neurologic outcome of patients with severe head injury. A multicenter, randomized controlled trial. JAMA 1996; 21; 276(7): 538 -43
